Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04648631 · ClinicalTrials.gov registry record · NA

Hidradenitis Suppurativa (HS) Tunneling Wounds

A NA study of Hidradenitis Suppurativa, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
15
Enrollment target
1
Study location

NCT04648631 is a NA study of Hidradenitis Suppurativa that has completed, run by University of Miami. The registered enrollment target is 15 participants, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04648631, a NA study of Hidradenitis Suppurativa, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacterial composition of the wounds.

Conditions Studied

Interventions

  • DEVICE antibiofilm surfactant wound gel (ABWG)

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2021-02-26
Est. Completion 2022-07-28
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT04648631

The ClinicalTrials.gov registry entry for NCT04648631 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 598-participant average among 52 other Hidradenitis Suppurativa trials with a reported enrollment target (97% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hidradenitis Suppurativa appearing as the primary indexed condition, and to 1 intervention - of which antibiofilm surfactant wound gel (ABWG) is the first listed.

NCT04648631 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04648631 about?

NCT04648631 is a clinical study titled "Hidradenitis Suppurativa (HS) Tunneling Wounds". The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacteria...

What is the current status of trial NCT04648631?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2021-02-26. Estimated completion is 2022-07-28.

What conditions does trial NCT04648631 study?

This clinical trial studies the following conditions: Hidradenitis Suppurativa.

What interventions are being tested in trial NCT04648631?

The interventions under investigation include: antibiofilm surfactant wound gel (ABWG) (DEVICE).

Who is sponsoring clinical trial NCT04648631?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04648631 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hidradenitis Suppurativa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.